Lexicon Pharmaceuticals, Inc.

LXRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$49,656$21,364$62,888$66,656
Short-Term Investments$66,294$117,643$131,951$171,301
Receivables$2,334$2,183$47,447$3,473
Inventory$158$168$201$231
Other Curr. Assets$4,085$3,726$3,319$4,532
Total Curr. Assets$122,527$145,084$245,806$246,193
Property Plant & Equip (Net)$9,489$6,588$6,954$7,316
Goodwill$44,543$44,543$44,543$44,543
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$29,368$29,368$368$368
Total NC Assets$83,400$80,499$51,865$52,227
Other Assets$0$0$0$0
Total Assets$205,927$225,583$297,671$298,420
Liabilities
Payables$3,797$5,899$10,689$14,801
Short-Term Debt$1,642$909$43,100$1,175
Tax Payable$0$0$0$0
Deferred Revenue$4,303$17,456$45,000$0
Other Curr. Liab.$11,978$10,572$11,904$29,272
Total Curr. Liab.$21,720$34,836$110,693$45,248
LT Debt$56,508$56,107$58,643$107,222
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,540$5,200$5,303$0
Total NC Liab.$64,048$61,307$63,946$107,222
Other Liabilities$0$0$0$0
Cap. Leases$1,642$909$1,044$8,099
Total Liabilities$85,768$96,143$174,639$152,470
Equity
Pref Stock$0$0$0$0
Common Stock$366$366$366$363
Retained Earnings-$2,002,054-$1,989,285-$1,992,537-$1,967,242
AOCI$29-$14$25$119
Other Equity$2,121,818$2,118,373$2,115,178$2,112,710
Total Equity$120,159$129,440$123,032$145,950
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$205,927$225,583$297,671$298,420
Net Debt$8,494$35,652$38,855$41,741
Lexicon Pharmaceuticals, Inc. (LXRX) Financial Statements & Key Stats | AlphaPilot